Who invested in Abionic

3 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$24Mraised across 3 rounds since 2014, from 3 sources

$4.0MSeries B$20MSeries C$83KGrant

Latest round: Grant, $83KJun 2023
Biggest round: $20MSeries C · Mar 2018
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2016201820202022

$4.0MSeries B$20MSeries C$83KGrant

First round: Series B, $4.0M
Biggest round: $20M
Usual gap between rounds: 5.2 years

The rounds

Jun 2023
Grant$83K2 new
- Venture Kick
- Verve Ventures
Source recorded
Mar 2018
Series C$20M1 new
- Pierangelo Bottinelli
Reported by Businesswire
Oct 2014
Series B$4.0M
No investor was named in the report.
From a historical funding record

Founders and team

From Abionic's own website: 2 founders, 3 on the team.

Iwan MärkiChief Technical Officer & Co-Founder

Nicolas DurandFounder

Patrick PestalozziChief Executive Officer
Guillaume HaquetteChief Biology Officer
Martine ReindleChairperson

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2014Series C2018Grant2023

Venture Kick

Verve VenturesPierangelo Bottinelli

Everyone who backed them

Venture KickAccelerator1round

Verve VenturesVC firm1round

Pierangelo Bottinellino record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Abionic as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.